Liatis, Stavros

Sympathetic system activity in obesity and metabolic syndrome

TENTOLOURIS, N., LIATIS, S., & KATSILAMBROS, N. (2006) · Annals of the New York Academy of Sciences

Adipokines, Inflammation, and Metabolic DiseasesRegulation of Appetite and Obesity

Cited by 260

Validation of the Finnish diabetes risk score (FINDRISC) questionnaire for screening for undiagnosed type 2 diabetes, dysglycaemia and the metabolic syndrome in Greece

Makrilakis, K., Liatis, S., Grammatikou, S., Perrea, D., Stathi, C., Tsiligros, P., & Katsilambros, N. (2011) · Diabetes & Metabolism

Diabetes, Cardiovascular Risks, and LipoproteinsHealth Promotion and Cardiovascular Prevention

Cited by 199

Sarcopenic Obesity: Epidemiologic Evidence, Pathophysiology, and Therapeutic Perspectives

Koliaki, C., Liatis, S., Dalamaga, M., & Kokkinos, A. (2019) · Current Obesity Reports

Nutrition and Health in AgingBody Composition Measurement Techniques

Cited by 176

The role of bariatric surgery to treat diabetes: current challenges and perspectives

Koliaki, C., Liatis, S., le Roux, C. W., & Kokkinos, A. (2017) · BMC Endocrine Disorders

Bariatric Surgery and OutcomesMinimally Invasive Surgical Techniques

Cited by 167

Effectiveness, reach, uptake, and feasibility of digital health interventions for adults with type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials

Moschonis, G., Siopis, G., Jung, J., Eweka, E., Willems, R., Kwasnicka, D., Asare, B. Y.-A., Kodithuwakku, V., Verhaeghe, N., Vedanthan, R., et al. (2023) · The Lancet Digital Health

Mobile Health and mHealth ApplicationsDiabetes Management and Education

Cited by 149

Effectiveness, reach, uptake, and feasibility of digital health interventions for adults with hypertension: a systematic review and meta-analysis of randomised controlled trials

Siopis, G., Moschonis, G., Eweka, E., Jung, J., Kwasnicka, D., Asare, B. Y.-A., Kodithuwakku, V., Willems, R., Verhaeghe, N., Annemans, L., et al. (2023) · The Lancet Digital Health

Mobile Health and mHealth ApplicationsBlood Pressure and Hypertension Studies

Cited by 87

Chronic administration of an angiotensin II receptor antagonist resets the hypothalamic–pituitary–adrenal (HPA) axis and improves the affect of patients with diabetes mellitus type 2: Preliminary results: Research Report

Pavlatou, M. G., Mastorakos, G., Lekakis, I., Liatis, S., Vamvakou, G., Zoumakis, E., Papassotiriou, I., Rabavilas, A. D., Katsilambros, N., & Chrousos, G. P. (2008) · Stress

Stress Responses and CortisolRenin-Angiotensin System Studies

Cited by 66

Comparison of health-related quality of Life (HRQOL) among patients with pre-diabetes, diabetes and normal glucose tolerance, using the 15D-HRQOL questionnaire in Greece: the DEPLAN study

Makrilakis, K., Liatis, S., Tsiakou, A., Stathi, C., Papachristoforou, E., Perrea, D., Katsilambros, N., Kontodimopoulos, N., & Niakas, D. (2018) · BMC Endocrine Disorders

Health Systems, Economic Evaluations, Quality of LifeDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 27